US$ 23.60
glp-1 colorectal cancer death risk study november 2025 🩺 Can a diabetes and weight-loss drug help rewrite the odds for colon survival? A new spotlights the potential of drugs—popularly used for type 2 diabetes and weight management—to GLP-1 drugs linked to dramatically
Description
SUSTAIN 7 investigators

Dehydration : GLP-1s often blunt thirst cues
The first developed molecule aimed to simultaneously activate glucagon and GLP-1 receptors for the treatment of obesity and glucose intolerance [35], improving body weight and glycemic control in a similar manner to exendin-4, a GLP-1 analogue [116]

Cardiovasc Res 117(11):e138e140

Companies receiving letters include Kin Meds, GoodGirlRx, WeightCare, and PharmaZee
